IMMP1L
Mitochondrial inner membrane protease subunit 1
Also known as: FLJ25059, IMMP1, IMP1L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96LU5
- Gene
- IMMP1L
- Ensembl
- ENSG00000148950
- Chromosome
- 11
- Canonical length
- 166 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
The mitochondrial inner membrane peptidase (IMP) complex generates mature, active proteins in the mitochondrial intermembrane space by proteolytically removing the mitochondrial targeting presequence of nuclear-encoded proteins. IMP1 and IMP2 (IMMP2L; MIM 605977) are the catalytic subunits of the IMP complex (Burri et al., 2005 [PubMed 15814844]).[supplied by OMIM, Sep 2008]
Canonical amino-acid sequenceUniProt
166 residues, UniProt reviewed canonical sequence.
>Q96LU5|IMMP1L
1 MLRGVLGKTF RLVGYTIQYG CIAHCAFEYV GGVVMCSGPS MEPTIQNSDI VFAENLSRHF
61 YGIQRGDIVI AKSPSDPKSN ICKRVIGLEG DKILTTSPSD FFKSHSYVPM GHVWLEGDNL
121 QNSTDSRCYG PIPYGLIRGR IFFKIWPLSD FGFLRASPNG HRFSDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IMMP1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 47 nTPM
- cerebellum: 46 nTPM
- basal ganglia: 46 nTPM
- amygdala: 41 nTPM
- tongue: 40 nTPM
- cerebral cortex: 36 nTPM
Single-cell type
- parietal cells: 216 nCPM
- myonuclei: 174 nCPM
- corticotrophs: 156 nCPM
- retinal horizontal cells: 122 nCPM
- distal convoluted tubule cells: 121 nCPM
- pancreatic islet cells: 119 nCPM
Immune cell
- plasmacytoid DC: 40 nTPM
- naive CD8 T-cell: 40 nTPM
- NK-cell: 38 nTPM
- T-reg: 36 nTPM
- memory B-cell: 34 nTPM
- eosinophil: 32 nTPM
Brain region
- cerebellum: 15 nTPM
- basal ganglia: 11 nTPM
- white matter: 10 nTPM
- cerebral cortex: 10 nTPM
- thalamus: 9.4 nTPM
- spinal cord: 9.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.42
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.28
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase S26A, signal peptidase I
- Peptidase S26
- LexA/Signal peptidase-like superfamily
- Signal peptidase, peptidase S26
- Mitochondrial Inner Membrane Protease Subunit 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IMMP1L as an antibody target. Whether an autoantibody or antibody against IMMP1L could matter depends on whether native IMMP1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IMMP1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IMMP1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...